The microbiome as a therapeutic target for multiple sclerosis: Can genetically engineered probiotics treat the disease? Diseases 2020, 8, 33. [Google Scholar] [CrossRef] Scolding, N.J.; Jones, J.; Compston, D.A.; Morgan, B.P. Oligodendrocyte susceptibility to injury by T-cell perforin. ...